Having a Negative MRI Does Not Mean That You Don't Have a Significant Cancer.

February 15, 2020
All Posts

Dr. David Morris discusses the evolution of MRI in prostate cancer and reviews scenarios where MRI may be best suited.  The impact MRI has on biopsy effectiveness, surgical planning decisions, and the limitations that can arise from using MRI to risk stratify patients are discussed. Dr. Morris also shares his personal experience and preference on how he uses MRI in his practice.  

In addition to MRI, Dr. Morris gives suggestions on how to improve active surveillance protocols, compliance tracking, and how genomic testing can physicians’ additional reassurance when placing a patient on active surveillance.   

Listen to other episodes here.